Risedronate Therapy for the Prevention of Steroid-induced Osteoporosis in Patients with Minimal-change Nephrotic Syndrome
Takashi Takei(Tokyo Women's Medical University), Kosaku Nitta(Tokyo Women's Medical University), Kunio Kawanishi(Tokyo Women's Medical University), Tetsuya Ogawa(Nihon University), Ari Shimizu(Tokyo Women's Medical University), Mitsuyo Itabashi(Tokyo Women's Medical University), Hidekazu Sugiura(Tokyo Women's Medical University), Shunji Shiohira(Tokyo Women's Medical University), Kazunori Karasawa(Tokyo Women's Medical University), Keiko Uchida(Tokyo Women's Medical University), Misao Tsukada(Tokyo Women's Medical University), Chiari Kojima(Tokyo Women's Medical University), Nobuyuki Amemiya(Tokyo Women's Medical University), Ken Tsuchiya(Tokyo Women's Medical University), Takahito Moriyama(Tokyo Women's Medical University)
Cited by 6
Related Papers
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
IP <sub>3</sub> Receptor Types 2 and 3 Mediate Exocrine Secretion Underlying Energy Metabolism
|Science|2005|317
M<sub>3</sub> muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice
|The Journal of Physiology|2004|191
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170
Left Ventricular Hypertrophy Is Associated with Arterial Stiffness and Vascular Calcification in Hemodialysis Patients
|Hypertension Research|2004|161